← Back to Discover
Vantage Consulting Group Inc
Period ended Dec 31, 2025 · Latest filing Feb 11, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Dec 31, 2025: $19,720,162
More quarters will appear as history becomes available.
Top holdings
Top 10 at Dec 31, 2025. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Babcock & Wilcox Enterprises Inc. · COM · 05614L209 · shares: $15,318,708
- ADC Therapeutics SA · COM · H0036K147 · shares: $2,410,983
- Cibus, Inc. · COM · 17166A101 · shares: $1,990,471
Reported holdings
3 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Babcock & Wilcox Enterprises Inc. | COM | 05614L209 | — | 2,416,200 shares | $15,318,708 |
| ADC Therapeutics SA | COM | H0036K147 | — | 682,998 shares | $2,410,983 |
| Cibus, Inc. | COM | 17166A101 | — | 1,143,949 shares | $1,990,471 |